VENLAFAXINE HYDROCHLORIDE
- Product NDC
- 61919-427
- 11-digit product format
- 619190427
- Labeler code
- 61919
- Product ID
- 61919-427_908dc8d9-6c95-0c40-e053-2a95a90a2e57
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VENLAFAXINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA090174
- Marketing category
- ANDA
- Marketing start
- 2019-08-20
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 38 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-427-30 | VENLAFAXINE HYDROCHLORIDE | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 3 |
| 61919-427-60 | VENLAFAXINE HYDROCHLORIDE | 60 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 60 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
| ETHYLCELLULOSE (100 MPA.S) | INACTIVE INGREDIENT | 47MLB0F1MV | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-427 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT RX] | 3 | Legacy NDC, 1 package rows | 20190425_3cfc589e-455e-4df3-91e6-6cfece5c420a.zip |
| 61919-427 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DIRECT_RX] | 1 | Legacy NDC, 1 package rows | 20220919_908dc8d9-6c94-0c40-e053-2a95a90a2e57.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 61919-427-30 | 61919042730 | 30 in 1 BOTTLE | Historical |
| 61919-427-60 | 61919042760 | 60 in 1 BOTTLE | Historical |